Virtual reality as a treatment for alcohol use disorder

Phase 2

• Conditions: Middelgerelateerde en verslavingsstoornissen; alcohol addiction; Alcohol use disorder

• Registration Number: NL-OMON51954
• Lead Sponsor: Parnassia (Den Haag)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

Alcohol use disorder

Exclusion Criteria

Severe interfering psychiatric disorders (acute mood disorders, acute psychotic
disorders and neuropsychiatric disorders).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main parameter is subjective craving. Subjective craving will be measured<br /><br>with questionnaires and participants will be asked to fill in the ASI, Mate<br /><br>CRIMI: verlangen and VAS before each treatment session. After the treatment<br /><br>session participants will be asked to fill in the VAS again. Three months after<br /><br>the last session participants will be asked to answer all the questionnaires<br /><br>mentioned above once more.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary parameter will be physiological craving and self-efficacy, measured<br /><br>by self-report. The non-invasive physiological measures are heart rate<br /><br>variability and skin conductance, which will be measured with the Biopac<br /><br>software. Third, after each virtual reality session, participants will be asked<br /><br>to fill in the therapy evaluation scale to investigate how participants<br /><br>experienced the virtual reality cue exposure therapy. Also, alcohol relapse<br /><br>will be monitored through self-report and routine urine drug monitoring.</p><br>